In today's views

• Strategy | Nile Pharma (NIPH) is closing in on Rameda and this may trigger arbitrage opportunities
• ISPH | The decline in ISPH stock price yesterday confirms that 3Q25 results are strong.
• VALU | 9M25 bottom line is consistent with a full year target of EGP750 million 
• ETEL | Share price is approaching our FV upper end of EGP73/share, what is incorporated and what’s not?
• MFPC | 3Q soft on volumes and  FX, but gas policy shield supports premium  
• EGCH | Resilient margins supported by pricing; operational recovery yet to show
• EKHO | 3Q25: On track for full-year guidance; 4Q25 poised for stronger finish
• LCSW | Economies of scale drive strong 3Q25; weak 4Q25 to derail EGP360m earnings target
• ORWE | Improved 3Q25 puts ORWE on track to meet revised 2025e guidance